IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v543y2017i7647d10.1038_nature21702.html
   My bibliography  Save this article

The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1

Author

Listed:
  • Andrew A. Wylie

    (Novartis Institutes for BioMedical Research)

  • Joseph Schoepfer

    (Novartis Institutes for BioMedical Research)

  • Wolfgang Jahnke

    (Novartis Institutes for BioMedical Research)

  • Sandra W. Cowan-Jacob

    (Novartis Institutes for BioMedical Research)

  • Alice Loo

    (Novartis Institutes for BioMedical Research)

  • Pascal Furet

    (Novartis Institutes for BioMedical Research)

  • Andreas L. Marzinzik

    (Novartis Institutes for BioMedical Research)

  • Xavier Pelle

    (Novartis Institutes for BioMedical Research)

  • Jerry Donovan

    (Novartis Institutes for BioMedical Research)

  • Wenjing Zhu

    (Novartis Institutes for BioMedical Research)

  • Silvia Buonamici

    (Novartis Institutes for BioMedical Research
    † Present addresses: H3 Biomedicine Target Biology, 300 Technology Square, Cambridge, Massachusetts 02139, USA.)

  • A. Quamrul Hassan

    (Novartis Institutes for BioMedical Research)

  • Franco Lombardo

    (Novartis Institutes for BioMedical Research)

  • Varsha Iyer

    (Novartis Institutes for BioMedical Research)

  • Michael Palmer

    (Novartis Institutes for BioMedical Research)

  • Giuliano Berellini

    (Novartis Institutes for BioMedical Research)

  • Stephanie Dodd

    (Novartis Institutes for BioMedical Research)

  • Sanjeev Thohan

    (Novartis Institutes for BioMedical Research)

  • Hans Bitter

    (Novartis Institutes for BioMedical Research)

  • Susan Branford

    (Centre for Cancer Biology, SA Pathology and University of South Australia)

  • David M. Ross

    (Haematology Directorate, SA Pathology)

  • Timothy P. Hughes

    (South Australian Health & Medical Research Institute (SAHMRI), North Terrace)

  • Lilli Petruzzelli

    (Novartis Institutes for BioMedical Research)

  • K. Gary Vanasse

    (Novartis Institutes for BioMedical Research)

  • Markus Warmuth

    (Novartis Institutes for BioMedical Research
    † Present addresses: H3 Biomedicine Target Biology, 300 Technology Square, Cambridge, Massachusetts 02139, USA.)

  • Francesco Hofmann

    (Novartis Institutes for BioMedical Research)

  • Nicholas J. Keen

    (Novartis Institutes for BioMedical Research)

  • William R. Sellers

    (Novartis Institutes for BioMedical Research)

Abstract

The selective allosteric ABL1 inhibitor ABL001 (asciminib) represents a new inhibitory mechanism for BCR–ABL1-driven malignancies, and its efficacy and evolving mechanisms of resistance do not overlap with those of other BCR–ABL1 kinase inhibitors.

Suggested Citation

  • Andrew A. Wylie & Joseph Schoepfer & Wolfgang Jahnke & Sandra W. Cowan-Jacob & Alice Loo & Pascal Furet & Andreas L. Marzinzik & Xavier Pelle & Jerry Donovan & Wenjing Zhu & Silvia Buonamici & A. Quam, 2017. "The allosteric inhibitor ABL001 enables dual targeting of BCR–ABL1," Nature, Nature, vol. 543(7647), pages 733-737, March.
  • Handle: RePEc:nat:nature:v:543:y:2017:i:7647:d:10.1038_nature21702
    DOI: 10.1038/nature21702
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature21702
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1038/nature21702?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Fanjun Li & Monifa A. Fahie & Kaitlyn M. Gilliam & Ryan Pham & Min Chen, 2022. "Mapping the conformational energy landscape of Abl kinase using ClyA nanopore tweezers," Nature Communications, Nature, vol. 13(1), pages 1-10, December.
    2. Tyler S. Beyett & Ciric To & David E. Heppner & Jaimin K. Rana & Anna M. Schmoker & Jaebong Jang & Dries J. H. Clercq & Gabriel Gomez & David A. Scott & Nathanael S. Gray & Pasi A. Jänne & Michael J. , 2022. "Molecular basis for cooperative binding and synergy of ATP-site and allosteric EGFR inhibitors," Nature Communications, Nature, vol. 13(1), pages 1-11, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:543:y:2017:i:7647:d:10.1038_nature21702. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.